Events in August 2022
-
Provider Event, Yorkshire & Humber Inpatient Detoxification Consortium
Provider Event, Yorkshire & Humber Inpatient Detoxification Consortium
–
August 3, 2022
Online
Wednesday, 3 August 2022
2:00pm – 4:00pmWe would like to invite you and your colleagues to a virtual event on Wednesday, 3rd August 2022 at 2.00 pm which will be held on Microsoft Teams. The purpose of this event is to reflect on the last year, referral criteria, preparation work with patients, pathways, referral process and an opportunity to ask questions as well as meet the teams.
This session is suitable for all Drug and Alcohol staff who work in the catchment of the Yorkshire and Humber consortia including newly qualified staff, treatment panel staff, residential provision staff, peer support workers, lived experience mentors, preparation and motivational group workers, key workers, nurse prescribers and medical staff.
It is important that people register through Eventbrite to receive the link for the event which will be shared 24 hours before the event.
-
Recent trends in benzodiazepine use: harms, challenges and best practice
Recent trends in benzodiazepine use: harms, challenges and best practice
–
August 18, 2022
Online event
Thu, 18 August 2022
3:00pm – 4:30pmDeaths related to drug poisonings in England and Wales have been steadily rising for almost a decade, with 2020 seeing a record 4,561 people dying.
Within that complexity, one rarely talked about trend stands out – the rise in deaths where benzodiazepines are implicated. This trend is already well understood in Scotland, where deaths involving benzodiazepines have increased by a staggering 500% since 2008.
This webinar will explore these trends and their implications for people who use drugs and the treatment and recovery system. We learn about the complex picture of benzodiazepine use – from prescribed drugs to newer illicit “street benzos” – and how services are tackling these challenges.
We will hear from a range of experts about the latest thinking and best practice in this area, and we will discuss how the system can better respond in the context of the government’s new Drug Strategy and funding for treatment and recovery.